Sökning: "Idiopathic pulmonary fibrosis"
Visar resultat 1 - 5 av 17 avhandlingar innehållade orden Idiopathic pulmonary fibrosis.
1. Mesenchymal heterogeneity in the adult human lung
Sammanfattning : The human lung is a complex tissue consisting of a heterogeneous mix of different structures and cells, each which a specific role that together contribute to the primary function of the organ: the gas exchange. Different mesenchymal cells populate the interstitial areas around airways and blood vessels and form the connective tissue together with the extracellular matrix. LÄS MER
2. Tissue remodelling in pulmonary fibrosis linked to 5-HT2 receptor activation
Sammanfattning : After an injury, an immediate reparative response is triggered to replace the damaged tissue, however, in fibrosis, cells remain active despite wound resolution causing a steady build-up of fibrotic tissue. In pulmonary fibrosis,there is a constant regeneration and remodelling of lung tissue where the thin architecture of alveoli become thickened, hampering efficient diffusion of oxygen, as seen in diseases like idiopathic pulmonary fibrosis (IPF). LÄS MER
3. Alveolar Progenitor Cells in Lung Damage and Regeneration in Pulmonary Fibrosis
Sammanfattning : .... LÄS MER
4. Idiopathic pulmonary fibrosis : disease presentation, clinical course and potential biomarkers
Sammanfattning : The interest and research within the area of the fatal lung disease idiopathic pulmonary fibrosis (IPF) has increased exponentially over the past decades. This has resulted in important insights into the nature and pathogenesis of the disease, which ultimately constitute the knowledge base upon which diagnostic, management, treatment decisions and guidelines are shaped. LÄS MER
5. Causes and treatment of chronic respiratory failure : experience of a national register
Sammanfattning : Long-term oxygen therapy (LTOT) or home mechanical ventilation (HMV) can improve survival time in chronic respiratory failure. A national quality register could be an aid to identifying risk markers and optimizing therapy for respiratory failure. LÄS MER